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Abstract
Background: The promoters of housekeeping genes are well-bound by RNA polymerase II (RNAP) in
different tissues. Although the promoters of these genes are known to contain CpG islands, the specific
DNA sequences that are associated with high RNAP binding to housekeeping promoters has not been
described.
Results:  ChIP-chip experiments from three mouse tissues, liver, heart ventricles, and primary
keratinocytes, indicate that 94% of promoters have similar RNAP binding, ranging from well-bound to
poorly-bound in all tissues. Using all 8-base pair long sequences as a test set, we have identified the DNA
sequences that are enriched in promoters of housekeeping genes, focusing on those DNA sequences
which are preferentially localized in the proximal promoter. We observe a bimodal distribution. Virtually
all sequences enriched in promoters with high RNAP binding values contain a CpG dinucleotide. These
results suggest that only transcription factor binding sites (TFBS) that contain the CpG dinucleotide are
involved in RNAP binding to housekeeping promoters while TFBS that do not contain a CpG are involved
in regulated promoter activity. Abundant 8-mers that are preferentially localized in the proximal
promoters and exhibit the best enrichment in RNAP bound promoters are all variants of six known CpG-
containing TFBS: ETS, NRF-1, BoxA, SP1, CRE, and E-Box. The frequency of these six DNA motifs can
predict housekeeping promoters as accurately as the presence of a CpG island, suggesting that they are
the structural elements critical for CpG island function. Experimental EMSA results demonstrate that
methylation of the CpG in the ETS, NRF-1, and SP1 motifs prevent DNA binding in nuclear extracts in
both keratinocytes and liver.
Conclusion: In general, TFBS that do not contain a CpG are involved in regulated gene expression while
TFBS that contain a CpG are involved in constitutive gene expression with some CpG containing
sequences also involved in inducible and tissue specific gene regulation. These TFBS are not bound when
the CpG is methylated. Unmethylated CpG dinucleotides in the TFBS in CpG islands allow the
transcription factors to find their binding sites which occur only in promoters, in turn localizing RNAP to
promoters.
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Background
The promoter region of genes is typically divided into two
regions: the core or basal promoter region and the proxi-
mal promoter. The core promoter region stretches from
around -50 bp to +20 bp and is the location in the pro-
moter where the pre-initiation complex forms and the
general transcriptional machinery assembles, including
RNA polymerase II (RNAP). The proximal promoter
extends from -200 bp to the transcriptional start site (TSS)
and contains transcription factor binding sites (TFBS) that
are critical for the recruitment of RNA polymerase II
(RNAP) to DNA [2-4]. In mammalian genomes, the CpG
dinucleotide occurs at 20% of the expected frequency [5]
and is typically methylated both in cell cuture and animal
tissues [6,7]. The exception is in CpG islands. CpG islands
are defined as regions in the DNA at least 200 bp long
where C+G comprise more than 50% of the nucleotides
and CpG dinucleotides occur at greater than 60% the
expected frequency (this represents roughly 8 or more
CpGs in 200 bp) [8]. The presence of CpG islands is asso-
ciated with gene regulatory regions [9] and in the promot-
ers of genes generally correlates with binding by RNA
polymerase II (RNAP) [9]. Promoters of housekeeping
genes are constitutively bound by RNAP in all tissues
while regulated promoters, either tissue specific or induc-
ible, are selectively bound by RNAP in only certain tis-
sue(s) or contexts respectively [2].
Three advances allow us to interrogate the genome-wide
properties of promoters. First is the availability of com-
plete genomic sequences. Second is the determination of
full-length cDNAs that can identify the TSS and proximal
promoter [10]. Third is the determination of the chroma-
tin architecture of the genome by the identification of
hypersensitive sites [11,12] or the location of particular
proteins or their modified forms using chromatin immu-
noprecipitation followed by microarray analysis (ChIP-
chip) [13]. Although ChIP-chip experiments have identi-
fied the location of RNAP and components of the preini-
tiation complex in particular tissues [9,14], these
experiments have not been done systematically over a
range of tissues.
We show that all and only CpG containing DNA
sequences are associated with RNAP binding to the same
promoter in multiple tissues. Many DNA sequences are
more abundant near the TSS than elsewhere [15-18] and
the six most abundant CpG containing sequences that are
localized in proximal promoters are known TFBS and can
predict RNAP binding to housekeeping promoters with
similar accuracy as the presence of CpG islands.
Results and discussion
Binding of RNAP and H3K9me2 to mouse promoters in 
keratinocytes, liver, and heart ventricles
To gain insight into the DNA sequence properties of
housekeeping promoters, we analyzed RNAP binding to
promoters in three mouse tissues: primary skin keratinoc-
ytes, liver, and heart ventricles. Using ChIP-chip experi-
ments [19], we determined the genomic localization of
initiating (hypo-phosphorylated) RNAP [20,21] in all
three tissues (Figure 1A–C). DNA from the RNAP ChIP
analysis was amplified and hybridized to Nimblegen
mouse promoter microarrays containing 15 probes span-
ning from -1,000 bp to +500 bp (see methods). Signal
intensities were averaged for each promoter to produce a
number representing binding at each promoter. This pro-
duced a graded binding of RNAP to promoter regions as
has been previously observed [9,14,22]. Raw data for
these ChIP-chip experiments can be found at the Vinson
laboratory Web site [1]. We limited the following analysis
of DNA sequence properties to the set of 14,790 promot-
ers that contains neither similar/duplicated sequences nor
a poorly annotated transcriptional start site (TSS).
To identify promoters that had similar RNAP binding val-
ues in all three tissues, we excluded genes where RNAP
binding between any pair of tissues was significantly dif-
ferent. This excluded 534 tissue-specific (356 in liver, 131
in heart, and 47 in keratinocytes) promoters, and 395
with high RNAP binding in two of the three tissues. The
remaining 13,861 promoters (94%) have similar RNAP
binding in all three tissues, some being well bound by
RNAP and others having little RNAP at the promoter (Fig-
ure 1D–F). For each of these 13,861 promoters, termed
common RNAP promoters, RNAP binding values from
the three tissues were normalized and averaged, produc-
ing a single number representing RNAP binding to a pro-
moter across the three tissues.
To investigate the DNA sequence properties of the 13,861
common promoters (-1,000 bp to +500 bp) and deter-
mine potential transcription factor binding sites (TFBS)
that are responsible for RNAP binding we analyzed the
occurrences of 8 bp-long DNA sequences (8-mers) in
common RNAP promoters. 8-mers were chosen because
their length is similar to that of known TFBS. 8-mers were
counted on the sense and anti-sense strands because, with
the exception of TATA [23], 8-mers are not restricted to a
single strand. Of all 32,896 8-mers (38% contain CpG) we
extensively characterized the 12,208 most abundant 8-
mers (see materials and methods) of which only 20%
contained a CpG highlighting that the CpG dinucleotide
is underrepresented even in promoter regions [15].BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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All 8-mers enriched in promoters well bound by RNAP in 
multiple tissues contain a CpG dinucleotide
To measure 8-mer enrichment in promoters commonly
bound by RNAP, we calculated the term "8-mer-associa-
tion-with-RNAP" for all 8-mers. This term is the average
RNAP binding to promoters that contain a particular 8-
mer normalized by the average RNAP binding to all com-
mon promoters. The value "8-mer-association-with-
RNAP" is calculated for each 8-mer by first identifying all
the promoters that contain that particular 8-mer, and then
averaging the RNAP binding values of those promoters.
These values are then normalized by dividing by the aver-
age of the RNAP binding values of all common promot-
ers. A histogram of these values has a bimodal
distribution. 20% of 8-mers are associated with high
RNAP binding to common RNAP promoters (Figure 2).
A-C) RNAP binding to 14,790 promoters from ChIP-chip data in different mouse tissues with each spot representing a single  promoter Figure 1
A-C) RNAPbinding to 14,790 promoters from ChIP-chip data in different mouse tissues with each spot repre-
senting a single promoter. A) keratinocytes versus heart ventricles (R = +0.76). B) keratinocytes versus liver (R = +0.73). 
C) heart ventricle versus liver (R = +0.76). D-F) RNAP binding to the 13,861 promoters with similar RNAP binding values in 
heart, liver and keratinocytes.BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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This result suggests that the graded binding of RNAP to
promoters is caused by a combination of 8-mers, some of
which favor RNAP binding and others which do not. The
region of the promoter (-1,000 bp to +500 bp) critical for
the observed bimodal distribution extends from -600 bp
to +400 bp (see Additional file 1). Strikingly, nearly all the
8-mers that are associated with RNAP binding contain the
CpG dinucleotide while virtually none of the remaining
8-mers contain a CpG. In contrast to the CpG dinucle-
otide, the other dinucleotides did not exclusively occur in
either part of the bimodal distribution (Additional file 2).
A spreadsheet containing the 8-mer-association-with-
RNAP for all 8-mers is included in the supplementary
material (Additional file 5).
To evaluate if other types of promoters have a different
enrichment of 8-mers, we examined the transcriptionally
inactive genes marked by a post-translationally modified
form of histone 3, H3K9me2 (lysine 9 containing a dime-
thyl group) [24,25]. In keratinocytes, ChIP-chip identifi-
cation of H3K9me2 genomic localization negatively
correlated with RNAP (correlation coefficient, R = -0.50)
(Figure 3A). The 8-mer-association-with-H3K9me2 also
had a bimodal distribution with the CpG containing 8-
mers associating the least with H3K9me2 binding (Figure
3B). As anticipated (comparing Figure 2 and 3B), practi-
cally all the 8-mers most associated with common RNAP
binding also are least associated with H3K9me2 binding
(Figure 3C). Similar results were obtained when all 8-mers
were examined (Additional file 3A–E).
8-mer-association-with-RNAP for abundant 8-mers calcu- lated for 13, 861 common promoters between -1,000 bp and  +500 bp Figure 2
8-mer-association-with-RNAP for abundant 8-mers 
calculated for 13, 861 common promoters between -
1,000 bp and +500 bp. 8-mers that contain a CpG are 
noted in black.
A) Binding of RNAP vs. H3K9me2 (R = -0.50) in mouse tis- sue culture keratinocytes Figure 3
A) Binding ofRNAPvs. H3K9me2 (R = -0.50) in mouse 
tissue culture keratinocytes.B) 8-mer-association-with-
H3K9me2 for 12,208 abundant 8-mers, calculated for 14,790 
promoters between -1,000 bp and +500 bp; CpG containing 
8-mers are noted in black. C-E) 8-mer-association-with-
RNAP vs. 8-mer-association-with-H3K9me2. C) All 8-mers. 
The association-with-RNAP and the association-with-
H3K9me2 for the core promoter elements at their unique 
position in promoters is presented for TATA (TATA-
WAAR), INR (YYANWYY) and DPE (RGWYV). D) 8-mers 
without a CpG. E) 8-mers with a CpG.BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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The 8-mers with and without a CpG were plotted sepa-
rately to highlight the few 8-mers that are the exception to
the general conclusion that only CpG containing
sequences are associated with RNAP binding to a promot-
ers (Figure 3D–E). The most notable exception is the
GACCAATC 8-mer, a CCAAT sequence that is enriched in
housekeeping promoters.
Previous work indicated that ~50% of human promoters
bound by RNAP contain the INR and DPE consensus
sequences between -200 bp and +200 bp [9]. To see if
these non-CpG-containing sequences were also excep-
tions to our general conclusion, we calculated the associ-
ation-with-RNAP and association-with-H3K9me2 for
TATA, INR and DPE in the set of promoters with similar
RNAP binding values in the three tissues we have exam-
ined. This was accomplished by averaging the binding val-
ues of those promoters that contained the consensus
sequence at the expected position [3]. In mouse, the con-
sensus TATA is uniquely positioned in only 1.8% of pro-
moters and has a very high association-with-H3K9me2
binding to promoters. The INR was uniquely positioned
in only 9% of promoters and is associated with H3K9me2
bound promoters. DPE is not uniquely positioned in pro-
moters, but occurs in 19% of promoters at the expected
location and is also associated with H3K9me2 binding
(Figure 3C). This suggests that TATA, INR and the DPE are
not important for RNAP binding to promoters in multiple
tissues. Presumably these sequences are important for tis-
sue-specific gene expression.
CpG sequences are also associated with mRNA expression
We examined whether RNAP binding to the promoter cor-
relates with mRNA expression levels in the genes whose
promoters are bound similarly by RNAP in the three tis-
sues examined. mRNA expression data for heart ventricle
was obtained [26] and compared to RNAP binding levels
for the 4,522 promoters that share a common identifier
(Figure 4A). We calculated the 8-mers-association-with-
mRNA-expression and found the same 8-mers associated
with RNAP binding to promoters also associated with
mRNA expression (Figure 4B). Thus, CpG-containing 8-
mers are most enriched in promoters that have the highest
RNAP binding and mRNA expression.
Sequences most enriched in tissue-specific promoters do 
not contain a CpG
The DNA sequence properties of tissue specific promoters
that were well bound by RNAP in only one tissue were
compared with housekeeping promoters well bound by
RNAP in all three tissues. The abundant 8-mers most
enriched in the 356 liver specific promoters do not con-
tain CpG and were different than those associated with
RNAP binding in all three tissues (Figure 5, Additional file
3F). As expected, the liver-specific transcription factor
HNF4 is enriched in the liver-specific genes. The fact that
TATA sequences are also enriched in the liver specific
genes is consistent with suggestions that it is a marker for
tissue specific, not constitutive gene expression [15,27].
Some CpG containing 8-mers are enriched in the liver spe-
cific genes indicating that in addition to their housekeep-
ing function, these sequences also mediate tissues specific
A) RNAP binding to promoters vs. mRNA expression for  4,522 promoters with common identifiers Figure 4
A) RNAPbinding to promoters vs. mRNA expression 
for 4,522 promoters with common identifiers.B) 8-
mer-association-with-RNAP vs. 8-mer-association-with-
mRNA-expression for abundant 8-mers calculated using the 
4,522 promoters graphed in (A). CpG-containing 8-mers are 
notated in black.
8-mer-association-with-RNAP vs. 8-mer enrichment in 356  liver specific promoters for abundant 8-mers Figure 5
8-mer-association-with-RNAPvs. 8-mer enrichment 
in 356 liver specific promoters for abundant 8-mers. 
Highlighted 8-mers contain TATA sequences (STable 1 in 
Additional file 4) and the liver specific HNF4 binding sites (8-
mers containing TGACCT). The CpG containing 8-mers are 
plotted in black.BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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gene expression. This has been well documented for the
CRE (TGACGTCA) [28,29].
Non-random distribution of 8-mers in promoters
If the 8-mers that associate with RNAP binding are TFBS,
they may be localized in the proximal promoter as has
been observed in human [15,16] and Drosophila promot-
ers [23]. We thus determined the "Clustering Factor" (CF,
a measure of non-random distribution between -1,000 bp
and +500 bp) [15,23] for abundant 8-mers in promoters,
and compared it to 8-mer-association-with-RNAP. Some
8-mers were preferentially localized near the TSS (Figure
6A–B). The 8-mers most associated with promoters com-
monly bound by RNAP had a high CF (Figure 6C, Addi-
tional file 3G). However, there was also a class of 8-mers
with high CFs but low 8-mer-association-with-RNAP val-
ues that may represent TFBS involved in regulated gene
expression.
The 120 8-mers with the statistically highest CF (Figure
6B) that localize upstream of the TSS could be manually
grouped into ten consensus motifs that are known TFBS:
ETS, NRF-1, E-Box, BoxA, CRE, SP1, KLF, CCAAT, TATA,
and CRE-T (STable 1 in Additional file 4), six of which
contain a CpG dinucleotide (ETS, NRF-1, E-Box, BoxA,
CRE, and SP1). A similar analysis has identified that these
ten motifs localize to the proximal promoter in human
promoters [15]. The six motifs that contain a CpG in the
consensus motif (ETS, NRF-1, E-Box, BoxA, CRE, and SP1)
always positively correlated with each other in the proxi-
mal promoter, exceeding expectations by up to two fold
(STable 2A in Additional file 4), were enriched in the 20%
of promoters best bound by RNAP in all three tissues
(STable 2B in Additional file 4), and were underrepre-
sented in H3K9me2 marked promoters (STable 2C in
Additional file 4). ETS, NRF-1, and BoxA correlate the best
with RNAP binding to promoters in multiple tissues (STa-
ble 2B in Additional file 4). Of the ten identified motifs,
only TATA and CRE-T were enriched in the 20% of pro-
moters best marked by H3K9me2 in keratinocytes (STable
2C in Additional file 4). To see if these TFBS play some
specific role in mRNA expression or RNAP binding, we
calculated the association-with-mRNA-expression and
association-with-RNAP for the consensus sequences of
these TFBS (Table 1). As expected, the CpG-containing
TFBS have high association values for both mRNA expres-
sion and RNAP binding.
CpG islands can be defined by two or more of the six CpG 
containing TFBS
Previous work has suggested that housekeeping genes can
be defined by the presence of a CpG island in the pro-
moter region [8], but the DNA sequences properties of
CpG islands has not been described. We evaluated if the
presence of the six CpG consensus motifs in proximal pro-
moters (-200 bp to the TSS) predicts RNAP binding to
promoters commonly bound by RNAP and compared
these results with the occurrence of a CpG island between
-200 bp to the TSS (Figure 7A). The results demonstrate
that the presence of any two of these motifs recapitulates
the discrimination based on the presence of a CpG island
in regards to RNAP binding to common promoters. In
order to compare these two measures, we grouped pro-
moters into ten equal size groups with increased RNAP
binding. 80% of promoters in the group best bound by
RNAP contain a CpG island and a similar number contain
two or more of the six motifs (Figure 7A). Similarly, only
5% of promoters with the lowest RNAP binding values are
A) A measure of non-random distribution termed a Clustering Factor (CF) is plotted in the most populated bin for 8-mers  with at least 20 members in the most populated 20 bp bin (abundant 8-mers) Figure 6
A) A measure of non-random distribution termed a Clustering Factor (CF) is plotted in the most populated 
bin for 8-mers with at least 20 members in the most populated 20 bp bin (abundant 8-mers). Note the dots 
between -100 bp and the TSS with large CF values representing 8-mers that are more abundant near the TSS than elsewhere. 
B) A probability term P for the 8-mers in (A). A P value of 24 means that the distribution of the 8-mer has a less than 10-24 
chance of being random. C) Non-random distribution of 8-mers (Clustering Factor) vs. 8-mer-association-with-RNAP for 
abundant 8-mers.BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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CpG islands, and only about 5% have two or more motifs
(Figure 7A). The presence of three or more of these motifs
produced a lower positive hit rate in the best bound group
(48%) but occurred in only 1% of promoters not bound
by RNAP. Therefore, our analysis suggests that CpG
islands have predictive value in defining housekeeping
genes because of the presence of these six TFBS motifs.
These six motifs do not account for all CpGs in CpG
islands. Some of the other CpGs are known TFBS but the
function of the rest remains unclear. They could be
sequences that persist because they are protected from
methylation and ultimate destruction or they could be
involved in the higher-level regulatory processes that have
been proposed for CpG islands [30]. In contrast to pro-
moters well bound by RNAP in multiple tissues, only 20%
of tissue specific proximal promoters are CpG islands and
similarly only 20% contain two or more of these six
motifs. This indicates that these six motifs correlate with
promoters that are bound by RNAP in multiple tissues
and not tissue specific promoters (Figure 7B).
Nuclear extracts do not bind TFBS with a methylated CpG
Methylation of CpG dinucleotides in CpG islands inhibits
promoter activity and occurs in many cancers where the
oncogenic event is the transcriptional suppression of
tumor suppressor genes [30]. One simple explanation is
that CpG methylation inhibits TFs from binding their
TFBS resulting in promoter inactivity. A more prevalent,
but not mutually exclusive view suggests that a more
active mechanism is functioning in which methyl binding
proteins bind methylated CpGs to facilitate chromatin
mediated occlusion of the promoter [30,31]. The effect of
CpG methylation on the function of five of the six CpG
containing TFBS (DNA binding and/or transcriptional
potential) that localize in the proximal promoter has been
described. The one exception is BoxA, for which the effect
of CpG methylation on DNA binding has not been
reported in the literature. In general, methylation inhibits
the activity of CpG containing TFBS [32]. CpG methyla-
tion is reported to inhibit the function of a CRE [33], ETS
[34], NRF-1 [35], and E-Box [36]. Other CpG containing
motifs are also inhibited via methylation including AP2
[37] and CTCF [38]. Methylation of the CpG in the SP1
motif, the most abundant CpG containing motif, is
reported to either not affect DNA binding [39-41], affect
binding when a cytosine flanking the CpG is methylated
[41,42] or inhibit binding [43].
We observe that CpG methylation of a canonical SP1, ETS,
or NRF-1 site abolishes DNA binding of nuclear extracts
isolated from either liver or primary keratinocytes (Figure
A) Fraction of promoters that contain particular sequences  between -200 bp and TSS: 1) CpG island, 2) two or more of  six CpG containing motifs (SP1: CCCGCC, CCGCCC,  CGCCCC; ETS: CCGGAA, GCGGAA; NRF-1:CGCAT- GCG, CGCGTGCG, CGCCTGCG; BoxA: TCTCGCG,  CTCGCGA; CRE: ACGTCA; E-Box: CACGTG), 3) three or  more of the six motifs Figure 7
A) Fraction of promoters that contain particular 
sequences between -200 bp and TSS: 1) CpG island, 
2) two or more of six CpG containing motifs (SP1: 
CCCGCC, CCGCCC, CGCCCC; ETS: CCGGAA, 
GCGGAA; NRF-1:CGCATGCG, CGCGTGCG, 
CGCCTGCG; BoxA: TCTCGCG, CTCGCGA; CRE: 
ACGTCA; E-Box: CACGTG), 3) three or more of 
the six motifs.B) Fraction of promoters that contain par-
ticular motifs: top 20% of common RNAP promoters 
(Const), liver specific (LS), heart ventricle specific (HS), and 
keratinocyte specific (KS) promoters. Average RNAP binding 
for each class is presented.
Table 1: Association of the 10 localized motifs with RNAP binding and mRNA expression.
Motif Sequence 8-mer-association-with-RNAP 8-mer-association-with-mRNA expression
BoxA TCTCGCGA 1.30 2.50
NRF-1 GCGVTGCG 1.24 2.44
ETS VCCGGAARY 1.21 2.39
CRE TGACGTCA 1.19 2.32
SP-1 CCCCGCCC 1.14 2.38
E-Box YCACGTGA 1.10 2.28
CCAAT RRCCAATSR 1.04 2.27
KLF CCCCTCCC 1.04 2.28
TATA TATAAAD 0.96 2.22
CRE-T TGATGTCA 0.90 2.17
Column one contains the name of the motif; column two contains the DNA sequence of the motif; column three is the 8-mer-association-with-
RNAP for promoters (-1,000 bp to +500 bp) commonly bound by RNAP in the three tissues examined ranked in order by association; column four 
is 8-mer-association-with-mRNA-expression.BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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8). When both DNA strands of a canonical SP1 site are
methylated, nuclear extract binding are abolished. For
ETS, methylation of a one strand of DNA is sufficient to
abolish DNA binding while for NRF-1, methyation of
both CpGs in the canonical site on either strand is suffi-
cient to abolished binding. As a control, we show that the
methylated SP1 oligonucleotides could bind to the non-
specific prokaryotic protein HU. Reexamination of previ-
ous reports indicates that SP1 methylation causes a mod-
est decrease in SP1 binding that our experimental system
is able to demonstrate more dramatically.
Conclusion
We identified promoters that are bound similarly by
RNAP in multiple tissues and determined the association
between the presence of 8-mers in these promoters and
the extent of RNAP binding to the promoter. Looking at
RNAP binding to housekeeping promoters, we observed a
bimodal distribution: only 8-mers with the CpG dinucle-
otide are in the class of sequences most associated with
RNAP binding and only 8-mers without a CpG are in the
class least associated with RNAP binding. An implication
of this observation is that knowing if a TFBS contains a
CpG reveals aspects of its biological function. If the TFBS
contains a CpG, it is involved in constitutive gene expres-
sion and if the TFBS does not contain a CpG, it is involved
in regulated gene expression. This insight will help iden-
tify potential functions for transcription factors when
their TFBS is identified. Additionally, if a transcription fac-
tor shows degeneracy in its TFBS [44,45], binding to a
CpG sequence and a similar sequence without a CpG, it
suggests that this transcription factor is involved in both
constitutive and regulated gene expression. This is
observed for the CRE and CRE-T sequences, two
sequences that are localized in the proximal promoter and
differ by a single base: CRE contains a CpG (TGACGTCA)
while CRE-T does not (TGATGTCA). The CREB protein
binds both sequences well (data not shown) but the two
sequences correlate very differently with RNAP binding
suggesting that the CREB transcription factor can regulate
either constitutive gene expression by binding the CRE
sequence or regulated gene expression by binding the
CRE-T sequence.
In vertebrates CpG dinucleotides are rare and usually are
methylated on the cytosine but do occur at close to the
expected frequency in clusters called CpG islands where
the CpGs remain unmethylated [30,46]. These CpG
islands often occur in promoters of housekeeping genes
[8,9]. We show that the presence of two or more of any of
the six CpG containing TFBS (SP1, ETS, NRF-1, CRE, E-
Box, and BoxA) in the proximal promoter can predict
RNAP binding to housekeeping promoters as accurately as
the presence of a CpG island in the proximal promoter.
Methylation of the CpG in the TFBS has been found to
inhibit the DNA binding for five of the six TFBS that are
abundant and localize in proximal promoters suggesting
this may be a general result for CpG containing TFBS.
Methylation dependent inhibition of transcription factor
binding to DNA has two implications. First, the transcrip-
tion factors that are critical for the activation of house-
EMSA using keratinocyte and liver nuclear extracts and pure HU protein with 28 bp double stranded oligonucleotides contain- ing on the sense strand a canonical SP1 (GGGGCGGG), ETS (CCGGAA), and NRF-1 (GCGVTGCG) site where the cytosine  in the CpG is non methylated (-/-), hemi-methylated (-/+), hemi-methylated (+/-), or methylated (+/+) Figure 8
EMSA using keratinocyte and liver nuclear extracts and pure HU protein with 28 bp double stranded oligonu-
cleotides containing on the sense strand a canonical SP1 (GGGGCGGG), ETS (CCGGAA), and NRF-1 
(GCGVTGCG) site where the cytosine in the CpG is non methylated (-/-), hemi-methylated (-/+), hemi-meth-
ylated (+/-), or methylated (+/+).BMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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keeping genes solve the problem of finding their TFBS in
the genome by only binding to unmethylated TFBS. Since
most CpGs in the genome are methylated, the only places
these transcription factors can bind are in the unmethyl-
ated CpG islands in promoters. Second, the pathological
methylation of CpG dinucleotides in CpG islands, as
occurs in many cancers [30], would prevent these abun-
dant transcription factors from binding their TFBS thus
causing the promoters to become inactive. This could be a
critical initial step that subsequently allows CpG methyl
binding proteins to bind to methylated CpGs and actively
repress a promoter [31].
Methods
Promoter annotation
Mouse (Mus musculus) annotation data and genomic DNA
sequences for the region -1,000 bp to +500 bp, relative to
the annotated transcription start site (TSS), were down-
loaded from the UCSC Genome Browser site (version
mm5, May 2004). This dataset contains the putative pro-
moter regions of 26,000 genes that are represented on the
MM5 minimum promoter mouse Nimblegen ChiP-chip
array. However, since the TSS for many of these genes is
poorly annotated (e.g. the TSS is the same as the transla-
tion start), we refined this dataset to include only those
genes where the distance between the TSS to the transla-
tion start (ATG) was greater than 30 nucleotides. This
reduced the total number of putative promoter regions to
15,180. We further reduced this number by excluding pro-
moter with gaps greater than 200 bps and the blastclust
program was used to confirm that this dataset did not con-
tain multiple copies of the same DNA sequences resulting
in 14,790 promoters.
The 14,790 analyzed promoters are a biased subset of the
26,000 promoters on the ChIP-chip array. The annotated
promoters are enriched 1.3 fold for the 20% of promoters
best bound by RNAP and depleted by 2 fold for H3K9me2
bound promoters. This could reflect that the H3K9me2
genes are not universally expressed and full-length cDNA
data does not exist for them, preventing identification of
a TSS.
Clustering Factor (CF) calculation
To determine if a DNA sequence has a non-random distri-
bution (i.e. clustered), we used an automated method of
detecting and quantifying peak height as described previ-
ously [15]. Abundant 8-mers contained 20 or more mem-
bers in a 20 base pair window in the 14,970 examined
promoters.
Cultures of primary keratinocytes
Primary keratinocytes were isolated from newborn FVB
mice epidermis [47]. Primary keratinocytes were seeded at
a density of 0.6 pelt or 5 × 106 cells per 100-mm dish in
Ca+2 and Mg+2 free EMEM (Cambrex Bio Science Walkers-
ville, Inc), supplemented with 8% Chelex (Bio-Rad, Rich-
mond, CA) treated FBS (Atlanta Biologicals, Inc), 0.2 mM
Ca2+ and Antibiotic-antimycotic. After 20 h, cultures were
washed with PBS and switched to the same medium con-
taining 0.05 mM Ca+2. After three days cells were used for
ChIP.
Liver and heart samples
Tissues from 5 adult FVB mice were frozen and ground in
fine powder in liquid nitrogen. After nitrogen evapora-
tion, samples were moved into a 50 ml conical tube and
10 mls of 1% formaldehyde in PBS was added and sam-
ples incubated for 10 minutes at 37°C with vortexing. 125
mM glycine was added for 5 minutes, cells were washed in
PBS with 1 mM PMSF once, dounced in Lyzis buffer (5
mM PIPES pH 8.0 85 mM KCL 0.5% NP40 1 mM NF 1
mM NaVa Roche protease inhibitors cocktail) and re-sus-
pended in 200 µl Nuclear lysis buffer (50 mM Tris-Cl pH
8.1 10 mM EDTA, 1% SDS proteases and phosphates
inhibitors as above). DNA was sheared by sonication to
yield fragments from 3,000 to 300 bp. Samples were cen-
trifuged and supernatants were diluted 6 times (0.01%
SDS, 1.1% Trition × 100, 1.2 mM EDTA, 16.7 mM Tris-Cl
pH 8.1, 167 mM NaCl) and used for ChIP.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed
using antibodies against RNAP from Covance, (8WG16)
that recognizes the unphosphorylated form of RNAP,
H3K9me2 from Upstate (07–441), and CREB using a mix-
ture of antibodies from Santa Cruz (sc-186) and Upstate
(06–863), c-Jun from Santa Cruz (sc-1694). The ChIP
protocol was from P. Farnham [19,48]. For immunopre-
cipitation, we used protein G agarose beads (Invitrogen).
Starting with 2 × 106 cells, we typically isolate 1 ng of ChIP
DNA for RNAP and 5 ng for histone H3K9me2.
ChIP DNA amplification and hybridization
Protocol for random DNA amplification [49,50] was
adapted from DeRisi lab. We used primers conjugated
with Cy3 or Cy5. After amplification 10–15 ug of DNA
was purified using Quiagen PCR purification Kit, concen-
trated by isopropanol precipitation and dried for 5 min
under vacuum. DNA was dissolved in 3 µl water, mixed
with Component A and Hybridization buffer (Nimble-
gen) according to manufacturer instructions. Amplified
ChIP DNA was hybridized to Nimblegen MM5 min
Mouse promoter microarrays containing 400,000 oligos
interrogating 26,000 promoters. Arrays were washed in
45C 0.2%SDS, 0.2%SSC for 15 sec, in the same buffer at
room temperature for 2 min, 0.2%SSC for one minute,
0.05% SSC for 15 sec. Arrays were dried by centrifugation
and scanned using Axon 4000B scanner. Images were
processed with NIMBLESCAN (Nimblegen) using defaultBMC Genomics 2008, 9:67 http://www.biomedcentral.com/1471-2164/9/67
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settings. Average of enrichment for fifteen spots represent-
ing one promoter were used as a measure of "binding" for
a protein. We averaged binding of RNAP and H3K9me2
from two independent hybridizations for each tissue
using independent biological samples. Correlation coeffi-
cients for keratinocytes replicates were: RNAP – 0.79,
H3K9me2 – 0.67 and for RNAP ChIP's from liver samples:
0.86; heart samples: 0.83.
Electrophoretic Mobility Shift Assay (EMSA)
Following PAGE purified 28 base pairs long oligonucle-
otides, the sense strand, with their complimentary strands
were purchased from Sigma-genosys (USA).
SP-1: GTCAGTCAGGGGG(C/Cm)GGGGCATCGGTCAG
ETS: GTCAGTCAGAC(C/Cm)GGAAGTTATCGGTCAG
NRF-1: GTCAGTCAGA(C/Cm)GCCTG(C/Cm)GTATCG-
GTCAG
A single consensus binding site for each transcription fac-
tor containing either nonmethylated (C) or methylated
cytosine (Cm) (1 methyleted cytosine in SP-1 and ETS and
2 in NRF-1) is underlined. Sense strands of non-methyl-
ated and methylated oligos were end labeled with (γ32P)
ATP (5000 mCi/mmol; MP Biomedical) using T4 PNK
enzyme (New England Biolabs). Equimolar labeled sense
and complimentary cold anti-sense oligos were annealed
by heating the mixture in annealing buffer to 65°C for 15
minutes and snap cooling it on ice for 2 minutes followed
by incubation at room temperature for 15 min. Annealing
resulted in four types of labeled double stranded oligos (1
non-methylated, 2 hemi-methylated oligos and 1 methyl-
ated oligo) and these were used for EMSA.
Nuclear extract was prepared from mouse liver and cul-
tured mouse primary keratinocytes [51]. In 20 µl of reac-
tion sample, 7 pg of labeled oligonucleotide (50,000
cpm) was added to 5 µg of nuclear extract, and incubated
in binding buffer (10 mM HEPES, 80 mM KCl, 0.05 mM
EDTA, 6% glycerol, 1 mM DTT and 1 mM MgCl2) at 37°C
for 20 min. Samples were separated on a 5% native PAGE
gel in 0.25 × TBE at 150 V for 1.5 hrs. Gels were dried and
exposed for autoradiography. For EMSA involving E. coli
HU protein, a kind gift from Shankar Adhya, 30 nM of
HPLC purified recombinant HU was incubated in binding
buffer (25 mM Tris-HCl pH 8.0, 50 mM KCl, 0.5 mM
EDTA, 2.5 mM DTT, 1 µg BSA) with 7 pg of labeled double
stranded oligo in a total volume of 20 µl and complex was
separated on 7.5% native page (0.25 × TBE, 150 V, 1.5
Hrs), dried and autoradiographed.
8-mer-association-with-binding
To find the "8-mer-association-with-binding" (b8), we
averaged the binding values of the promoters (bp) whose
sequence contained that 8-mer and divided by the average
of the binding values to the promoters ( ).
Where p is the promoter in question. ∂8p is equal to one if
the 8-mer occurs in the promoter sequence and zero oth-
erwise. Summing over p implies summing over all the pro-
moters in the set in question.
Promoters with similar RNAP binding
In order to identify promoters with similar RNAP binding
in two tissues, we rotated the data so that the best-fit line
was the 45-degree line through the origin. The two-
dimensional rotation matrix is:
where θ is the angle by which we rotated the coordinates
in the two-dimensional plane. For a given pair of data sets,
this angle can be determined by subtracting the angle of
the best-fit line from 45 degrees. For each data point, the
rotated values are calculated by operating the rotation
matrix on the original data point. The line can be forced
to the origin by adding or subtracting the value of the ver-
tical-intercept of the best-fit line from the vertical data
before the rotation. The new "rotated binding values" are
then determined by operating on the original binding val-
ues:
In order to assure that the rotation was robust and not
heavily influenced by outliers in the data set, we tempo-
rarily removed data more than one standard deviation
from the original best fit line. If the best-fit line of the
transposed data still maintained its 45-degree angle
within some small error range, we concluded the data was
successfully rotated. If not, then we repeated the proce-
dure using the new rotated values and only those points
within one standard deviation of the best-fit line to deter-
mine the new rotation angle and intercept adjustment.
This was repeated until the best-fit line did not signifi-
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cantly alter with the removal of data points more than one
standard deviation from 45 degree line.
In our case we had RNAP binding values for three distinct
tissues: primary mouse keratinocytes, heart ventricle, and
liver. We knew that the results are similar in all three tis-
sues, with the exception of genes involved with tissue-spe-
cific expression in those tissues. We rotated the data by
pairs in the method described above. This took several
iterations since the rotation of one pair might affect the
values of another pair. The end result was new "rotated
binding values" for the promoters in each of the three tis-
sues. These values were then averaged to produce the
"Average RNAP binding" of that promoter in all three tis-
sues.
Determining Tissue Specific Promoters
Promoters which were more than two standard deviations
off of the 45-degree best-fit line (as determined above)
through any of the three pair of data (liver-heart, liver-
keratinocytes, and heart-keratinocytes), were considered
"tissue-specific" (not commonly bound). Of our original
set of 14,790 promotes, 929 were not commonly bound
by RNAP in all three tissues, leaving 13,861 promoters
which were commonly bound in all three tissues. Of 929
promoters that were not commonly bound by RNAP, tis-
sue specific promoters were selected based on following
criteria using the raw RNAP binding values:
356 liver specific promoters: L > 1.5 × H, L > 1.5 × K, H<
1.5 (raw RNAP binding value), K < 1.5
131 heart specific promoters: H > 1.3 × L, H > 1.3 × K, L <
1.5, K < 1.5
47 keratinocytes specific promoters: K > 1.5 × L, K > 1.5 ×
H, H < 1.5, L < 1.5
Where L stands for RNAP binding value in liver, H is
RNAP binding in heart and K – RNAP binding in keratino-
cytes.
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